Lichen Planopilaris (LPP) in women with Afro-textured hair
Scalp oils: a therapeutic or harmful catalyst for LPP? Principal author: Shirley McDonald Supporting research author: Celestine Gitau The objective of the study is to determine whether the influence of scalp oils are a contributory factor in the cause and severity of the scarring hair loss condition Lichen Planopilaris (LPP). This work was supported by […]
Clinical Trial for Alopecia Areata
Please see the information below that has been sent to us to share with our members, regarding a double-blind controlled trial of a new topical treatment for mild-moderate alopecia areata that has recently started in the UK. The trial is sponsored by a UK pharma company (Manentia). Members of The Institute of Trichologists have been […]
IOT Guidance Statement – Invasive Treatments
Important – Please Read At present, there is very little regulation to help protect patients regarding qualifications required in determining who can administer invasive treatments/injectables. There are consultations in process which mean this SHOULD come into place within the next few years. At present, microdermabrasion is considered a beauty therapist led procedure, but the ‘general […]
Adult Stem Cell Released Molecules in Combination with Microneedling Restore Hair Growth
The Institute of Trichologists’ Member Dr Michael Ryan collaborated in a study looking at adult stem cell released molecules in combination with microneedling restoring hair growth. Introduction: Alopecia is a chronic dermatological disorder affecting millions of people, in which people lose some or all of the hair on their head. Although alopecia has many forms, […]
Alopecia Areata Epidemiology
PROFESSOR ANDREW MESSENGER MD FRCP A study on the epidemiology of alopecia areata in the UK has recently been published in the British Journal of Dermatology [1]. It is currently online only but due to appear in print in the near future in open access form. The investigators used a large primary care database containing […]
Dupilumab in Alopecia Areata
PROFESSOR ANDREW MESSENGER MD FRCP There are an increasing number of case reports and small case series describing hair regrowth following treatment with the monoclonal antibody drug dupilumab. Dupilumab is licensed for treating atopic dermatitis and the original observations were serendipitous in patients who happened to have alopecia areata as well as dermatitis. Although there […]
Following historical “tracks” of hair follicle miniaturisation in patterned hair loss: Are elastin bodies the forgotten aetiology?
May 2021 The Institute of Trichologists’ Member Dr Hugh Rushton collaborated in a study that followed historical “tracks” of hair follicle miniaturisation in patterned hair loss. ABSTRACT: Pattern hair loss (PHL) is a chronic regressive condition of the scalp, where follicular miniaturisation and decreased scalp hair coverage occurs in affected areas. In all PHL cases, […]
Shedding light on therapeutics in alopecia and their relevance to COVID-19
December 2020 The Institute of Trichologists’ President Professor Andrew Messenger collaborated in a study that reported on therapeutics in alopecia and their relevance to COVID-19. ABSTRACT: As of July 9, 2020, there were more than 12 million confirmed cases of coronavirus disease 2019 (COVID-19) across the globe, with more than 550,000 deaths. Many European countries, including Belgium, […]
First Grey Hair Gene is Discovered
March 2016 The Institute of Trichologists’ Vice President Professor Tobin recently collaborated in an international study that reported on the discovery of several genes associated with hair traits, including the first grey hair gene. The study was lead by UCL and Professor Tobin’s collaborative research was carried out at The University of Bradford. The finding […]
